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Abstract Purpose: To examine
the physical properties and chemical
composition of particles captured by
in-line microfilters in critically ill
children, and to investigate the
inflammatory and cytotoxic effects
of particles on endothelial cells
(HUVEC) and macrophages in vitro.
Methods: Prospective, observa-
tional study of microfilters following
their use in the pediatric intensive
care unit. In vitro model utilizing
cytokine assays to investigate the
effects of particles on human endo-
thelial cells and murine macrophages.
Results: Twenty filter membranes
from nine patients and five controls
were examined by electron micro-
scopy (EM) and energy dispersion
spectroscopy (EDX). The average
number of particles found on the
surface of the used membranes was
550 cm2. EDX analysis confirmed
silicon as a major particle constituent.
Half of the filter membranes showed
conglomerates containing an
uncountable number of smaller parti-
cles. In vitro, glass particles were
used to mimic the high silicon content
particles. HUVEC and murine mac-
rophages were exposed to different
contents of particles, and cytokine
levels were assayed to assess their
immune response. Levels of inter-
leukin-1beta, interleukin-6,
interleukin-8, and tumor necrosis
factor alpha were suppressed.
Conclusions: Particle contamina-
tion of infusion solutions exists
despite a stringent infusion regiment.
The number and composition of par-
ticles depends on the complexity of
the applied admixtures. Beyond pos-
sible physical effects, the suppression
of macrophage and endothelial cell
cytokine secretion in vitro suggests
that microparticle infusion in vivo
may have immune-modulating
effects. Further clinical trials are
necessary to determine whether par-
ticle retention by in-line filtration has
an influence on the outcome of
intensive care patients.
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Introduction
One million particles per patient may be infused daily in
an intensive care setting, where a potential risk appears
against the background of debilitation and impaired host
responses [1, 2]. Mechanisms of particle damage to vari-
ous organs have been postulated, including effects on
microcirculation causing thrombi and granuloma forma-
tion [3–5]. Use of in-line filtration almost completely
prevents particulate infusion [6]. Recent studies have
evaluated the clinical effect of in-line filtration and
showed significant reduction in thrombophlebitis [7] and a
trend towards reduction of complications in neonates such
as sepsis, thrombosis, and necrotizing enterocolitis [8].
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To evaluate the effects of microfilters in the pediatric
intensive care unit (PICU), we carried out detailed
examinations of filters after their use. Electron micro-
scopy (EM) visualized particles adhering to the
membrane, and energy dispersion spectroscopy (EDX)
revealed their chemical compositions [9]. Based on these
data immune-modulating effects on human umbilical vein
endothelial cells (HUVEC) and murine macrophages
(RAW 264.7) were analyzed in vitro.
Materials and methods
Prior to this study, the infusion regiment in the PICU was
optimized to prevent precipitation and incompatibilities
using a computer-based analysis. Solutions and thera-
peutics were prepared according to the manufacturers’
recommendations. Approval by the ethics committee and
parental consent were obtained.
EM and EDX
Twenty-five Pall ELD96LLCE/NEO96E filters with
0.2 lm pore size (Pall, Dreieich, Germany) were ana-
lyzed. Twenty filters from nine patients were randomly
chosen after 72 h. Five unused filters served as controls
(see Table 1, ESM). For detailed information see ESM.
Cell culture
To simulate the in vivo situation, glass particles (2–
20 lm) were chosen to mimic the silicon content of
particles found on the filters. Contamination with lipo-
polysaccharide (LPS) was excluded. Inflammatory effects
were analyzed on RAW 264.7 (gamma NO-, ATCC
CRL-2278) and HUVEC (CC2517). Cytotoxic particle
load was determined by release of adenylatkinase (Toxi-
Light test) and lactate-dehydrogenase (LDH-cytotoxicity
test). Experiments were performed at subtoxic loads.
Cells were incubated with glass particles at contents from
0 to 500 lg/ml. Release of interleukin 1-beta (IL-1b),
interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor
necrosis factor alpha (TNFa) was measured after 4, 8,
and 24 h with ELISA kits for IL-1b (DY201), IL-6
(DY406), IL-8 (DY208), and TNFa (DY410; all kits by
R&D Duoset).
Cells were additionally incubated with 1 lg/ml LPS,
and HUVEC cells with 1 ng/ml TNFa as well. Results of
ELISA are given as the median of repeated determina-
tions. ToxiLight test results reflect the mean of four trials
and considered values within three standard deviations of
the controls as nontoxic. Statistics were processed by
Dunnett’s test [10].
Results
EM and EDX analysis
The average number (range) of particles on the surface of
the negative controls was 45.6 particles/cm2 (6–93 parti-
cles/cm2). Used filters showed a mean of 550 particles/
cm2 (8–1,993 particles/cm2), which was significantly
higher than the mean particle load of controls (P \ 0.001).
Particle size ranged from 5 to [100 lm with the
majority between 5 and 50 lm. EDX analysis detected
silicon, carbon, oxygen, sodium, chloride, potassium,
calcium, magnesium, iron, and aluminum. Phosphorus,
thallium, fluorine, chromium, copper, zinc, sulfur, barium,
and nickel were seldom found. Only carbon and oxygen
may be part of the membrane itself. Gold was added
during preparation. Silicon was the most frequently
detected element in analysis of individual particles. These
particles were notable for their angular shape and crys-
talline appearance (Fig. 1a, b).
Fifty percent of analyzed filters showed conglomerates
on the surfaces, containing uncountable numbers of par-
ticles. Figure 1c shows a conglomerate, detected on a
filter used for parenteral nutrition and heparin (filter 12,
Table 1, ESM). Parenteral nutrition was highly concen-
trated with an osmolarity [1,300 mosm/l. EDX analysis
revealed different elements as components of the con-
glomerate (e.g., carbon, sodium, potassium). It
demonstrates the spectrum of elements and is represen-
tative of other analyzed particles. Results of particle
counts and data of the applied fluids/therapeutics are
shown in Table 1 of the ESM. Data suggest a correlation
between the complexity of the infusion regiment and the
particle load (Fig. 1, ESM).
Cell culture (HUVEC/RAW 264.7)
Cytotoxicity
ToxiLight and LDH-cytotoxicity tests found that particle
loads [500 lg/ml were toxic in RAW 264.7 and HU-
VEC. For detailed information on cytotoxicity tests, see
ESM.
HUVEC and IL-8 After incubation of HUVEC with
glass particles, IL-8 increased significantly in samples of
300 lg (P \ 0.05) and 500 lg (P \ 0.01) particles/ml.
Additional stimulation of HUVEC with 1 lg/ml LPS or
1 ng/ml TNFa led to a 10-fold increase in IL-8 in samples
incubated with particle concentrations above 300 lg/ml.
Samples with particle dilution of 10 lg/ml and above
showed significant suppression of IL-8 at 4 and 8 h after
incubation with LPS (Fig. 2, ESM). Increased IL-8 levels
were detected for 300 and 500 lg/ml (data not shown).
HUVEC and IL-1b After 8 and 24 h incubation,
concentrations of IL-1b were significantly suppressed
708
(P \ 0.05) (Fig. 2). Adding 1 lg/ml LPS did not change
the IL-1b secretion. Also stimulation of HUVEC with
1 ng TNFa/ml revealed no significant variation after 4
and 8 h. Samples could not be analyzed for IL-1b con-
centration after 24 h since over 80% of cells died.
RAW 264.7 and TNFa In macrophages, control samples
from 4 to 24 h showed a high spontaneous release of
TNFa. Increasing the particle load resulted in reduction of
TNFa after 4–8 h. Only after incubation of 24 h was a
significant dose-related stimulation detected (P \ 0.01)
(data not shown).
RAW 264.7 and IL-6 Significant suppression of IL-6
concentration occurred after an incubation period of 8 h
with a particle load of 10 lg/ml. In the remaining sam-
ples, incubation of RAW with glass particles did not show
any dose-related release of IL-6. Incubation with 1 lg/ml
LPS for 4 h revealed a doubling of IL-6 concentration
without any dose-related effects of particles. After 24 h a
significant reduction of IL-6 was detected (data not
shown).
Discussion
Our results confirmed the existence of particulate con-
tamination in infusions despite a stringent infusion regime
in the PICU. Different contents of particles were found,
and data suggest that particle exposure is dependent on
the complexity of infusions and medications. These
findings are in keeping with the results of Mehrkens et al.
[1], who showed that bolus injections mainly increase
particulate contamination of the administered fluids.
Considering the detection limit of 5 lm, the detected
amount underestimates the particle exposure. Fifty per-
cent of the analyzed membranes showed conglomerates
containing uncountable numbers of particles. Smaller
particles were retained in the three-dimensional mesh-
work of the membrane and were disregarded. Most
particles were between 5 and 50 lm, which is more than
the diameter of lung and tissue capillaries [11] and may
cause obstruction. This supports the findings of Puntis
et al. [4] that particles cause granulomatous arteritis after
parenteral nutrition as demonstrated by post-mortem
study of 73 infants.
In accordance with other authors, we identified silicon
as a major chemical component [12], which originates
mainly from storage in glass ampoules [13].
Fig. 1 Particle (a) with corresponding EDX analysis (b) and
conglomerate (c) found by electron microscopy on the surface of
different filters. Presented filter (a) was used for the application of
bolus injections of multiple different therapeutics via a central
venous line. The size of the particle is approximately 40 9 20 lm.
It shows the representative angular shape and crystalline appear-
ance. In addition to the large particle, many smaller particles and
the incipient blockage of the filter membrane are apparent. The
corresponding EDX (b) revealed silicon as the major chemical
element. The second filter (c) was used for high osmolar parenteral
nutrition ([1,300 mosmol/l) via a central venous catheter in a
4-month-old infant after liver transplantation. The EDX analysis
revealed carbon, sodium, chloride, potassium, selene, silicon, and
phosphate as components of the conglomerate
Fig. 2 Interleukin-1beta concentration (pg/ml) after 4, 8 and 24 h
incubation period of HUVEC with different glass particle concen-
trations. After 8 h incubation with glass particles the release of
interleukin-1beta was significantly reduced independent from
particle content. Values are mean of four separate assays ±standard
deviation of all samples. *p \ 0.05; **p \ 0.01
709
In addition to mechanical obstruction, inflammatory
response of different organ systems after particle expo-
sure is possible [3, 14, 15]. To mimic these mechanisms,
we exposed macrophages and endothelial cells to particles
similar to those found on the filters. Our experiments with
endothelial cells showed significant suppression of IL-1b
after incubation with particles for 8 and 24 h. Comparable
results were assessed for IL-8. This effect was aggravated
by LPS. In macrophages, different particle loads sup-
pressed the secretion of TNFa. Similar effects were
evident for IL-6, which was significantly suppressed after
8 h incubation. Increased IL-8 was found after incubation
with 300–500 lg/ml particles. This was probably due to
cytotoxicity as was seen for comparable particle contents
in pre-tests.
Previously published data suggest an activation of the
immune system by particles [15]. In contrast, our exper-
iments showed a reduced cytokine release. Immune
paralysis is an accepted phenomenon in sepsis or after
ischemia or trauma, as confirmed by clinical and experi-
mental studies [16–19]. The importance of the exact
regulation of the chemokine release and the balance of
pro-inflammatory and anti-inflammatory mediators in this
phase of the disease is not exactly clear. Small changes
may have an influence and alter the process of over-
coming the disease. Foreign particles may interfere with
this phase of the disease when the patient is especially
vulnerable.
Lehr et al. [5] demonstrated that stress increases the
harmful effects of particles. Their animal model revealed
a reduction in capillary density in post-ischemic muscles
after particle infusion, in cases without preceding ische-
mia, no change in density was detectable.
A documented benefit of filtration is the prevention of
infusion phlebitis [7]. Less information exists for the
influence of filtration on severely ill patients. One single-
center trial on 88 preterm newborns showed a trend
toward decreased morbidity in the treatment group [8].
However, the incidence of sepsis could not be reduced by
in-line filtration [20].
According to the data of a preceding analysis, 70% of
our PICU patients were provided with a central-venous
line with three lumina for standardized infusion therapy.
Despite this standard, our examinations demonstrate that
particle exposure continues to be an unpredictable risk for
patients receiving infusion therapy.
Review of literature and our data suggest that particles
are capable of modulating cytokine secretion and may
exert harmful effects beyond mechanical obstruction.
Whether particles affect the outcome of PICU patients has
to be further evaluated.
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